```html

Quincke’s Edema (Angioedema) – A Comprehensive Medical Guide

Overview

Quincke’s edema, more commonly called angioedema, is a rapid‑onset swelling of the deeper layers of the skin and mucous membranes. The swelling typically involves the lips, eyelids, tongue, face, hands, feet, and sometimes the airway. Unlike a superficial rash, the swelling is non‑pitting and can be painful or uncomfortable.

Angioedema can be hereditary (genetic) or acquired (triggered by allergens, medications, or other medical conditions). Although it can affect anyone, certain groups are more prone:

• Women are slightly more likely to experience drug‑induced angioedema (≈55% of cases). [1] CDC, 2022
• People of Northern European descent have a higher prevalence of hereditary angioedema (HAE) due to C1‑inhibitor deficiency. [2] WHO, 2021
• Individuals using ACE inhibitors (a common blood‑pressure medication) have a 0.2–0.7% risk of developing angioedema each year. [3] Mayo Clinic, 2023

Overall prevalence is estimated at 1 in 10,000 people for hereditary forms and 0.1–0.5% for drug‑induced or acquired types. [4] NIH, 2022

Symptoms

Symptoms develop suddenly, often within minutes to a few hours after exposure to a trigger. The hallmark is deep, non‑pitting swelling, but other signs may accompany it.

Typical manifestations

• Lips, tongue, or throat swelling – can cause difficulty speaking or swallowing.
• Eyelid and facial swelling – may appear "puffy" and can affect vision if periorbital.
• Hands, feet, or genitalia swelling – often painless but can restrict movement.
• Abdominal angioedema – cramp‑like pain, nausea, vomiting, and occasional ascites (fluid buildup). More common in HAE.
• Dermal itching or burning – less common than with urticaria, but may be present.

Red‑flag symptoms that suggest airway involvement

• Feelings of throat tightness or a "lump in the throat"
• Hoarseness or change in voice
• Difficulty swallowing liquids
• Wheezing, stridor, or noisy breathing
• Rapid swelling of the tongue or floor of the mouth

These signs require immediate emergency care (see the “When to Seek Emergency Care” section).

Causes and Risk Factors

Angioedema results from increased permeability of blood vessels in the deep dermis and submucosal tissues. The underlying pathways differ based on the type.

1. Histamine‑mediated angioedema

• Allergic reactions – foods (e.g., peanuts, shellfish), insect stings, latex.
• Medications – penicillins, non‑steroidal anti‑inflammatory drugs (NSAIDs), contrast dyes.
• Associated with urticaria (hives) in ~70% of cases. [5] Cleveland Clinic, 2022

2. Bradykinin‑mediated angioedema

• ACE inhibitor (ACE‑I) use – drugs such as lisinopril, enalapril, or captopril.
• Hereditary Angioedema (HAE) – genetic deficiency or dysfunction of C1‑esterase inhibitor (C1‑INH). Two main types:
  • Type I (≈85%): low C1‑INH levels.
  • Type II (≈15%): normal levels but dysfunctional C1‑INH.
• Acquired C1‑INH deficiency – often related to lymphoproliferative disorders or auto‑immune disease.

3. Other triggers

• Physical factors – cold, heat, pressure, or vibration (e.g., from tight clothing).
• Hormonal influences – estrogen‑containing oral contraceptives can exacerbate HAE. [6] NIH, 2021
• Stress – can precipitate episodes in susceptible individuals.

Risk Factors

• Family history of HAE or unexplained swelling.
• Current use of ACE inhibitors or ARBs (in rare cases).
• Underlying autoimmune or lymphoproliferative disease.
• Female sex (due to hormonal modulation of bradykinin pathways).

Diagnosis

Diagnosing angioedema is primarily clinical, but laboratory testing helps differentiate histamine‑ versus bradykinin‑mediated forms.

Step‑by‑step approach

1. History & physical examination – onset, duration, location, known triggers, medication list, and family history.
2. Assess airway patency – visual inspection of the oropharynx; listen for stridor.
3. Laboratory tests (if not an acute emergency):
   • C4 complement level – low in HAE; normal in histamine‑mediated.
   • C1‑esterase inhibitor level and function – distinguishes Type I vs. Type II HAE.
   • Complete blood count, CRP – to rule out infection.
4. Allergy testing – skin prick or specific IgE testing when allergic cause is suspected.
5. Imaging (rare) – CT or MRI of the neck if airway edema is questionable or if underlying structural lesions are suspected.

In the emergency setting, treatment often begins before definitive labs are back, especially when airway compromise is possible.

Treatment Options

Treatment goals are to halt swelling, relieve symptoms, and prevent recurrence. Management differs according to the underlying mechanism.

1. Acute management – airway first

• Airway protection – early endotracheal intubation or cricothyrotomy if swelling threatens breathing.
• Oxygen supplementation – if hypoxemia is present.

2. Histamine‑mediated angioedema

• Antihistamines – second‑generation H1 blockers (cetirizine 10 mg, loratadine 10 mg) are first‑line; add H2 blocker (ranitidine 150 mg) if needed.
• Corticosteroids – oral or IV prednisone 40–60 mg (or equivalent) for severe cases.
• Epinephrine – intramuscular 0.3 mg of 1:1000 solution for life‑threatening swelling, especially when accompanied by anaphylaxis.

3. Bradykinin‑mediated angioedema

• C1‑INH concentrate (plasma‑derived or recombinant) – 20 U/kg IV for HAE attacks. [7] WHO, 2022
• Icatibant – a selective bradykinin B2‑receptor antagonist; 30 mg subcutaneously, repeat every 6 h if needed.
• Ecallantide – a kallikrein inhibitor; 30 mg subcutaneously (max 3 doses per day).
• For ACE‑inhibitor induced cases, immediate discontinuation of the ACE‑I is mandatory; no antihistamines or steroids are typically effective.

4. Long‑term prophylaxis

• HAE prophylaxis – lanadelumab (subcutaneous monoclonal antibody, 300 mg every 2 weeks) or berotralstat (oral, 150 mg daily).
• ACE‑I‑related – switch to an alternative antihypertensive (e.g., calcium‑channel blocker, ARB with caution).
• Allergy avoidance – strict elimination of known food or drug triggers.

5. Lifestyle & supportive measures

• Cold compresses for localized swelling (non‑compressive).
• Hydration and avoidance of alcohol or extreme temperature extremes.
• Carrying an emergency action plan and, when appropriate, an epinephrine auto‑injector.

Living with Quincke’s Edema (Angioedema)

Chronic or recurrent angioedema can affect quality of life, social activities, and mental health. Here are practical tips:

• Maintain a detailed diary – record episodes, possible triggers, medications, and response to treatment.
• Education – teach family, coworkers, and school staff how to recognize early signs and administer emergency medication.
• Medical ID – wear a bracelet or necklace indicating “Angioedema – may need epinephrine.”
• Regular follow‑up – schedule appointments with an allergist/immunologist at least annually or after any change in pattern.
• Psychological support – consider counseling or support groups; anxiety about attacks is common.
• Vaccinations – keep up‑to‑date, especially flu and COVID‑19, as infections can precipitate attacks.

Prevention

Prevention strategies differ based on the type of angioedema:

General measures

• Read medication labels; avoid NSAIDs or ACE inhibitors if you have a known sensitivity.
• Identify and eliminate food allergens; consult a dietitian if needed.
• Stay hydrated and avoid extreme temperature changes.
• Limit alcohol consumption – it can increase bradykinin levels.

Specific to hereditary angioedema

• Prophylactic medications (lanadelumab, berotralstat) as prescribed.
• Consider hormonal management – low‑dose estrogen contraceptives may worsen HAE; discuss alternatives with your physician.
• Avoid dental or surgical procedures that may trigger swelling without pre‑procedural C1‑INH cover.

Complications

If left untreated, angioedema can lead to serious outcomes:

• Airway obstruction – the most urgent life‑threatening complication; can cause hypoxia, cardiac arrest, or death.
• Bronchial edema – leading to severe asthma‑like symptoms or respiratory failure.
• Secondary infection – prolonged swelling may break skin integrity.
• Psychologic impact – chronic fear of attacks can cause anxiety, depression, and social withdrawal.
• Adverse drug reactions – repeated use of high‑dose steroids or antihistamines may cause metabolic disturbances.

When to Seek Emergency Care

---

Sources:

• [1] Centers for Disease Control and Prevention. “Adverse Effects of ACE Inhibitors.” 2022.
• [2] World Health Organization. “Hereditary Angioedema: Global Prevalence and Management.” 2021.
• [3] Mayo Clinic. “Angioedema – Overview.” Updated 2023.
• [4] National Institutes of Health. “Angioedema Fact Sheet.” 2022.
• [5] Cleveland Clinic. “Urticaria and Angioedema.” 2022.
• [6] National Institutes of Health. “Hormonal Influences on Hereditary Angioedema.” 2021.
• [7] World Health Organization. “Guidelines for the Use of C1‑Inhibitor Concentrates.” 2022.

```